Review calls for age-specific immunotherapy in childhood brain tumors

Pediatric brain tumors are the deadliest form of childhood cancer, yet most treatments are adapted from adult care and often miss the mark. A new study led by a second-year medical student at Dell Medical School at The University of Texas at Austin outlines why kids' brain tumors are uniquely hard to treat and where the next generation of therapies is heading.

👉 Full Story